Monday, April 25, 2016

BRIEF-Merck's phase iii tailor landmark study demonstrates significant benefits of Erbitux in combination with FOLFOX over FOLFOX alone

* Says phase iii tailor landmark study demonstrates

significant benefits of erbitux in combination with FOLFOX over

FOLFOX alone

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)